0.9% w/v sodium chloride solution for intravenous infusion, Panzyga 100 mg/ml Infusionslösung
NGAM-13
Phase 3 small_molecule active
Quick answer
0.9% w/v sodium chloride solution for intravenous infusion, Panzyga 100 mg/ml Infusionslösung for Pediatric acute-onset neuropsychiatric syndrome (PANS) is a Phase 3 program (small_molecule) at Maze Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Maze Therapeutics
- Indication
- Pediatric acute-onset neuropsychiatric syndrome (PANS)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active